Christer Paul

Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer

Sören Lehmann, Vladimir J.N. Bykov, Dina Ali et al. · Journal of Clinical Oncology · 2012 · 404 citations · Full text

Medicine, Oncology, Pharmacology +17

Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy.

Sigurd Vitols, Bo Angelin, S Ericsson et al. · Proceedings of the National Academy of Sciences · 1990 · 129 citations

Life Sciences, Biochemistry, Oncology +11

Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia

Stefan Deneberg, Michael Grövdal, Mohsen Karimi et al. · Leukemia · 2010 · 119 citations

Life Sciences, Genetics, Molecular Biology +14

BCRP mRNA expression v. clinical outcome in 40 adult AML patients

Bertil Uggla, Elisabet Ståhl, Dick Wågsäter et al. · Leukemia Research · 2004 · 99 citations

Life Sciences, Hematology, Molecular Biology +6

P-Glycoprotein Inhibitor Valspodar (PSC 833) Increases the Intracellular Concentrations of Daunorubicin In Vivo in Patients With P-Glycoprotein–Positive Acute Myeloid Leukemia

Ulf Tidefelt, Jan Liliemark, Astrid Gruber et al. · Journal of Clinical Oncology · 2000 · 98 citations

Medicine, Pharmacology, Pharmacotherapy +17